Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Yap

Showing results (91-100 of 260) with videos related to

Pageof 26
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2019
PARP Inhibitors: Extending Benefit Beyond <i>BRCA</i>-Mutant CancersPatrick G Pilié, Carl M Gay, Lauren A Byers, et al.
Current Problems in Cancer|February 19, 2017
Targeting the PD-1/PD-L1 axis in non-small cell lung cancerRajiv Kumar, Dearbhaile Collins, Saoirse Dolly, et al.
Nature Reviews. Clinical Oncology|December 3, 2024
Synthetic lethal strategies for the development of cancer therapeuticsNatalie Y L Ngoi, David Gallo, Carlos Torrado, et al.
Cancer Treatment and Research|November 17, 2023
Targeting ATR in Cancer MedicineCarolina Salguero, Christian Valladolid, Helen M R Robinson, et al.
Frontiers in Oncology|January 24, 2022
Application of Real-World Data to External Control Groups in Oncology Clinical Trial Drug DevelopmentTimothy A Yap, Ira Jacobs, Elodie Baumfeld Andre, et al.
Cancer Cell|December 19, 2025
Circulating tumor DNA as a biomarker in early phase clinical trialsHarold N Tan, Mitchell J Elliott, Ian M Silverman, et al.
Trends in Cancer|June 23, 2021
Development of poly(ADP-ribose) polymerase inhibitor and immunotherapy combinations: progress, pitfalls, and promisesMelissa M Pham, Natalie Y L Ngoi, Guang Peng, et al.
Cancer Discovery|April 3, 2021
Development of Immunotherapy Combination Strategies in CancerTimothy A Yap, Eileen E Parkes, Weiyi Peng, et al.
Nature Reviews. Clinical Oncology|February 20, 2024
Targeting ATR in patients with cancerNatalie Y L Ngoi, Patrick G Pilié, Daniel J McGrail, et al.
Nature Reviews. Drug Discovery|July 23, 2016
Drug discovery in advanced prostate cancer: translating biology into therapyTimothy A Yap, Alan D Smith, Roberta Ferraldeschi, et al.
Pageof 26

Showing results (91-100 of 260) with videos related to

Sort By:
Pageof 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2019
PARP Inhibitors: Extending Benefit Beyond <i>BRCA</i>-Mutant CancersPatrick G Pilié, Carl M Gay, Lauren A Byers, et al.
Current Problems in Cancer|February 19, 2017
Targeting the PD-1/PD-L1 axis in non-small cell lung cancerRajiv Kumar, Dearbhaile Collins, Saoirse Dolly, et al.
Nature Reviews. Clinical Oncology|December 3, 2024
Synthetic lethal strategies for the development of cancer therapeuticsNatalie Y L Ngoi, David Gallo, Carlos Torrado, et al.
Cancer Treatment and Research|November 17, 2023
Targeting ATR in Cancer MedicineCarolina Salguero, Christian Valladolid, Helen M R Robinson, et al.
Frontiers in Oncology|January 24, 2022
Application of Real-World Data to External Control Groups in Oncology Clinical Trial Drug DevelopmentTimothy A Yap, Ira Jacobs, Elodie Baumfeld Andre, et al.
Cancer Cell|December 19, 2025
Circulating tumor DNA as a biomarker in early phase clinical trialsHarold N Tan, Mitchell J Elliott, Ian M Silverman, et al.
Trends in Cancer|June 23, 2021
Development of poly(ADP-ribose) polymerase inhibitor and immunotherapy combinations: progress, pitfalls, and promisesMelissa M Pham, Natalie Y L Ngoi, Guang Peng, et al.
Cancer Discovery|April 3, 2021
Development of Immunotherapy Combination Strategies in CancerTimothy A Yap, Eileen E Parkes, Weiyi Peng, et al.
Nature Reviews. Clinical Oncology|February 20, 2024
Targeting ATR in patients with cancerNatalie Y L Ngoi, Patrick G Pilié, Daniel J McGrail, et al.
Nature Reviews. Drug Discovery|July 23, 2016
Drug discovery in advanced prostate cancer: translating biology into therapyTimothy A Yap, Alan D Smith, Roberta Ferraldeschi, et al.
Pageof 26